News

Obesity, diabetes fuel liver disease epidemic

Publish date: February 5, 2013

 

m.zoler@elsevier.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Ranbaxy Recalls Atorvastatin
MDedge Endocrinology
Osteoporosis, Vertebral Fractures May Flag Heart Risk in RA
MDedge Endocrinology
PCSK9 Antibodies Safely Cut LDL in Phase II
MDedge Endocrinology
Statins' Diabetogenic Impact Influenced by Underlying Risks
MDedge Endocrinology
Metabolic bone disease markers poor in CKD patients with HF
MDedge Endocrinology
Vitamin D lowered aldosterone in heart failure
MDedge Endocrinology
How to prevent 1 million coronary events
MDedge Endocrinology
HDL-raising: A good hypothesis gone bad
MDedge Endocrinology
Smoking ups mortality threefold
MDedge Endocrinology
Low-carb diet didn't boost CV risk
MDedge Endocrinology

Related Articles